Symbiox Investment & Trading Company Ltd Q1 FY27 Results
SYMBIOXQ1 FY27 ResultsAnnounced 12 Aug, 4:06 pmResult:Steady· Market: Surged#Cost led#Margin expansion#Base effect
| Metric | Value (₹ Cr) | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 0.26 | 69.1% | 44.3% |
| Total Income | 0.26 | 69.1% | 44.5% |
| Expenditure | 0.15 | 81.4% | 59.2% |
| PBT | 0.10 | 533.3% | 15.6% |
| Net Profit | 0.08 | 533.6% | 15.6% |
| OPM | 41.21% | 39.13pp | 21.74pp |
| NPM | 30.28% | 28.81pp | 15.74pp |
| EPS | 0.03 | 25.0% | 50.0% |
Core revenue fell sharply (-44% YoY) on a negligible base, and the 15.5% PAT growth was driven purely by cost-led margin expansion rather than business growth, so it's in-line/ordinary despite the profit uptick.
Informational and educational content only. Not investment advice.